Back to Search Start Over

Function of CSF1 and IL34 in Macrophage Homeostasis, Inflammation, and Cancer

Authors :
WeiYu Lin
Daqi Xu
Cary D. Austin
Patrick Caplazi
Kate Senger
Yonglian Sun
Surinder Jeet
Judy Young
Donnie Delarosa
Eric Suto
Zhiyu Huang
Juan Zhang
Donghong Yan
Cesar Corzo
Kai Barck
Sharmila Rajan
Carrie Looney
Vineela Gandham
Justin Lesch
Wei-Ching Liang
Elaine Mai
Hai Ngu
Navneet Ratti
Yongmei Chen
Dinah Misner
Tori Lin
Dimitry Danilenko
Paula Katavolos
Estelle Doudemont
Hirdesh Uppal
Jeffrey Eastham
Judy Mak
Patricia E. de Almeida
Katherine Bao
Azadeh Hadadianpour
Mary Keir
Richard A. D. Carano
Lauri Diehl
Min Xu
Yan Wu
Robby M. Weimer
Jason DeVoss
Wyne P. Lee
Mercedesz Balazs
Kevin Walsh
Kathila R. Alatsis
Flavius Martin
Ali A. Zarrin
Source :
Frontiers in Immunology, Vol 10 (2019)
Publication Year :
2019
Publisher :
Frontiers Media S.A., 2019.

Abstract

Colony-stimulating factor 1 (CSF1) and interleukin 34 (IL34) signal via the CSF1 receptor to regulate macrophage differentiation. Studies in IL34- or CSF1-deficient mice have revealed that IL34 function is limited to the central nervous system and skin during development. However, the roles of IL34 and CSF1 at homeostasis or in the context of inflammatory diseases or cancer in wild-type mice have not been clarified in vivo. By neutralizing CSF1 and/or IL34 in adult mice, we identified that they play important roles in macrophage differentiation, specifically in steady-state microglia, Langerhans cells, and kidney macrophages. In several inflammatory models, neutralization of both CSF1 and IL34 contributed to maximal disease protection. However, in a myeloid cell-rich tumor model, CSF1 but not IL34 was required for tumor-associated macrophage accumulation and immune homeostasis. Analysis of human inflammatory conditions reveals IL34 upregulation that may account for the protection requirement of IL34 blockade. Furthermore, evaluation of IL34 and CSF1 blockade treatment during Listeria infection reveals no substantial safety concerns. Thus, IL34 and CSF1 play non-redundant roles in macrophage differentiation, and therapeutic intervention targeting IL34 and/or CSF1 may provide an effective treatment in macrophage-driven immune-pathologies.

Details

Language :
English
ISSN :
16643224
Volume :
10
Database :
Directory of Open Access Journals
Journal :
Frontiers in Immunology
Publication Type :
Academic Journal
Accession number :
edsdoj.f5bbd900f7f94b86b15fbd853c8ad352
Document Type :
article
Full Text :
https://doi.org/10.3389/fimmu.2019.02019